Iovanace Biotherapeutics (IOVA) PT Lowered to $38 at Oppenheimer Seeing CEO Departure Adding Material Risk
Tweet Send to a Friend
Oppenheimer analyst Mark Breidenbach lowered the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $38.00 (from $51.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
